ArticleCureus2025

Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis.

Hiroyuki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.